Biblio

Found 6 results
[ Author(Asc)] Title Type Year
Filters: First Letter Of Title is A and Author is Edmond F. O'Donnell  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
O
E. F. O'Donnell, Koch, D. C., Bisson, W. H., Jang, H. S., and Kolluri, S., The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells, Cell death & disease, vol. 5, p. e1038, 2014.
E. F. O'Donnell, Saili, K. S., Koch, D. C., Kopparapu, P. R., Farrer, D., Bisson, W. H., Mathew, L. K., Sengupta, S., Kerkvliet, N. I., Tanguay, R., and , The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor, PLoS One, vol. 5, p. e13128, 2010.
E. F. O'Donnell, Saili, K. S., Koch, D. C., Kopparapu, P. R., Farrer, D., Bisson, W. H., Mathew, L. K., Sengupta, S., Kerkvliet, N. I., Tanguay, R. L., and Kolluri, S., The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor, PLoS ONE, vol. 5, no. 10, p. e13128, 2010.
E. F. O'Donnell, Jang, H. Sang, Pearce, M. C., Kerkvliet, N. I., and Kolluri, S., The aryl hydrocarbon receptor is required for induction of p21cip1/waf1 expression and growth inhibition by SU5416 in hepatoma cells., Oncotarget, vol. 8, no. 15, pp. 25211-25225, 2017.
E. F. O'Donnell, Kopparapu, P. Rao, Koch, D. C., Jang, H. Sang, Phillips, J. Lynne, Tanguay, R. L., Kerkvliet, N. I., and Kolluri, S. Kumar, The aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells., PLoS One, vol. 7, no. 7, p. e40926, 2012.
E. F. O'Donnell, Saili, K. S., Koch, D. C., Kopparapu, P. R., Farrer, D., Bisson, W. H., Mathew, L. K., Sengupta, S., Kerkvliet, N. I., Tanguay, R. L., and Kolluri, S. Kumar, The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor., PLoS One, vol. 5, no. 10, 2010.